News | Clinical Decision Support | November 17, 2016

HealthMyne Demonstrations at RSNA 2016 to Benefit Cancer Patients

For every attendee that takes part in a demonstration of its Quantitative Imaging Decision Support platform, HealthMyne will donate $25 to Madison, Wis. charity supporting cancer patients and their families

November 17, 2016 — HealthMyne has partnered with Gilda’s Club of Madison (Wis.) in an effort to make a difference in the lives of children and adults living with cancer during the 2016 Radiological Society of North America (RSNA) annual meeting.

For each RSNA attendee that takes part in a demo of HealthMyne’s Quantitative Imaging Decision Support (QIDS) software platform, the company will make a $25 donation to Gilda’s. Gilda’s offers support for those with cancer, but it also provides support for the entire family throughout their entire journey. This includes support groups, lectures, workshops and a variety of social events. Those attendees that take part will have an opportunity to sign their name to the “Donation Board” and get an “I Donated” sticker to proudly display their kind deed.

The QIDS platform combines imaging data with electronic medical record, radiation therapy and other clinical systems information to provide clinical decision support in the primary read. Currently focused on radiology and oncology, with future expansion into other specialties, QIDS (pronounced ‘quids’) is designed to positively impact clinical productivity and prepares radiologists for the transition to value-based payment.

HealthMyne asserts that in order for radiologists to extend their value as a member of the care team, highly curated evidence-based narratives, imaging analytics and patient cohort analysis must be generated to provide clinical decision support in the primary read, thereby enabling improved cancer diagnosis, staging and treatment.

For more information: www.healthmyne.com

Related Content

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019.

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019. Photo by Dave Fornell.

Feature | Artificial Intelligence | February 07, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
News | Remote Viewing Systems | December 27, 2019
December 27, 2019 — The Radiological Society of North America (RSNA) and Carequality have developed the Imaging Data
Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) Protecting Access to Medicare Act (PAMA) will require physicians to consult a CMS-approved clinical decision support mechanism before ordering advanced imaging exams for fee-for-service Medicare patients
News | Clinical Decision Support | December 26, 2019
December 26, 2019 — Effective Jan.
Applying radiology and cardiology PACS ergonomics expertise to help pathologists avoid repetitive stress injuries that can arise from adopting digital pathology
News | PACS Accessories | October 04, 2019
Applying radiology and cardiology PACS ergonomics expertise to help pathologists avoid repetitive stress injuries that...
NetDirector Launches Cloud-based PDF to DICOM Conversion Service
News | PACS | August 08, 2019
NetDirector, a cloud-based data exchange and integration platform, has diversified their radiology automation options...
Videos | Radiology Business | August 02, 2019
Association for Medical Imaging Management (AHRA) President ...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).